Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPH - Cytoclonal Pharmaceutics -- Ignore unavailable to you. Want to Upgrade?

To: vibaby who wrote (166)	6/16/1998 2:06:00 PM
From: Labrador	Read Replies (1) \| Respond to of 428

i re-read the release and went LONG. The stock is at $11. This is clearly an oversold position. How's that for an about-face. Go CYPH!!!

To: vibaby who wrote (166)	6/16/1998 2:08:00 PM
From: Roger A. Babb	Respond to of 428

Obviously a big seller was waiting on the news. Covered my short at 11 1/4

To: vibaby who wrote (166)	6/16/1998 7:50:00 PM
From: Axxel	Read Replies (1) \| Respond to of 428

J/M net buyers as usual-FYI-just ask the street...and the agreement does not cover product sales!....If you are negative, you better know your stuff...note also no lock on use for kidney or lung...wanna go short...OK...I'm sure J/M will sell someday...but it wasn't today...today they took the stock from you...see you at...er...a...maybe...a...er...twenty? Who knows....shall we wait and see? That would be a nifty place to cover a short...that would be just "ducky." Do the research...find out the depth of the market...BMY sold $940,000,0000 of TAXOL for breast cancer...THE LARGEST DRUG FOR THIS DISEASE AND THE GOVERNMENT WANTS THE COST OF THE TREATMENT [DRUG] BROUGHT DOWN! Best regards,